Govt Job for M.Pharm, M.Sc as Project Manager at IGIMS

IGIMS was established on 19th November 1983, as an autonomous organisation on the pattern of All India Institute of Medical Sciences (AIIMS), New Delhi.

The objective was to provide super specialty medical facilities in Bihar. On 27th January 1983 Cabinet approved the completion of this massive project in 4 phases within a span of six (6) years.

According to the decision of State Government, 130.20 Acres of land was transferred to IGIMS.

Walk-In-Interview for the post of Project Manager on contractual basis under research project “To Establish Clinical Trial Networks for hospital-based trial in Ophthalmology”.

Post : Project Manager (01 UR)

Qualification : Candidate should possess 1st Class Master’s Degree in Life Sciences or 1st Class M.Pharm or any equivalent degree from a recognized university,

4 years of core experience in managing/monitoring of regulatory clinical trials specially Vaccine/drug trial from reputed Institutions OR 2nd Class M.Sc. or

2nd Class M.Pharm or any equivalent degree with Ph.D. Degree in relevant subjects from a recognized university,

4 years of core experience post Ph.D. in managing/monitoring of regulatory clinical trials specially Vaccine/drug trial from reputed Institutions.

Salary : 50,000/month
Age limit : 40 years
Remarks : Relaxation of age as per rule prescribed.

Candidates having requisite qualification & experience with a copy of complete BIO-DATA with their original papers and its photocopy with two passport size photographs may come on same day (i.e 03/04/2021) at 09:00 AM for their document verification in the office chamber of the HOD, RIO, IGIMS, Patna.

No TA/DA is allowed for appearing in the interview and for verification of the document. Director, IGIMS, Patna reserves the right to cancel the recruitment process at any stage without assigning any reason.

A Walk-in interview of eligible Indian Citizen for appointment of above post has been fixed on 03/04/2021 at 11:00 A.M. in the office Chamber of the HOD, RIO, IGIMS, Patna

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert